Befiradol

Befiradol
Clinical data
ATC code
  • none
Legal status
Legal status
  • In general: uncontrolled
Identifiers
  • 3-Chloro-4-fluorophenyl-[4-fluoro-4-([(5-methylpyridin-2-yl)methylamino]methyl)piperidin-1-yl]methanone
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H22ClF2N3O
Molar mass393.86 g·mol−1
3D model (JSmol)
  • Cc1ccc(nc1)CNCC2(CCN(CC2)C(=O)c3ccc(c(c3)Cl)F)F
  • InChI=1S/C20H22ClF2N3O/c1-14-2-4-16(25-11-14)12-24-13-20(23)6-8-26(9-7-20)19(27)15-3-5-18(22)17(21)10-15/h2-5,10-11,24H,6-9,12-13H2,1H3 checkY
  • Key:PKZXLMVXBZICTF-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Befiradol (F-13,640; NLX-112) is an experimental drug being studied for the treatment of levodopa-induced dyskinesia. It is a potent and selective 5-HT1A receptor full agonist.

Pharmacology

In recombinant cell lines expressing human 5-HT1A receptors, befiradol exhibits high agonist efficacy for a variety of signal transduction read-outs, including ERK phosphorylation, G-protein activation, receptor internalization and adenylyl cyclase inhibition.[1] In rat hippocampal membranes it preferentially activates GalphaO proteins.[1] In neurochemical experiments, befiradol activated 5-HT1A autoreceptors in rat dorsal Raphe nucleus as well as 5-HT1A heteroreceptors on pyramidal neurons in the frontal cortex.[2] In rat models, it has powerful analgesic and antiallodynic effects comparable to those of high doses of opioid painkillers, but with fewer and less prominent side effects, as well as little or no development of tolerance with repeated use.[3][4][5][6][7]

A structure–activity relationship (SAR) study revealed that replacement of the dihalophenyl moiety by 3-benzothienyl increases maximal efficacy from 84% to 124% (Ki=2.7 nM).[8][9]

History

Befiradol was discovered and developed by Pierre Fabre Médicament, a French pharmaceuticals company who initially developed it as a treatment for chronic pain. In September 2013, befiradol was out-licensed to Neurolixis, a US-based biotechnology company. Neurolixis announced that it intended to re-purpose befiradol for the treatment of levodopa-induced dyskinesia in Parkinson's disease.[10] In support of this indication, Neurolixis received several research grants[11] from the Michael J. Fox Foundation and preclinical data was published describing the activity of befiradol in animal models of Parkinson's disease.[12][13] Studies published in 2020 using non-human primate models of Parkinson's disease, (MPTP-treated marmosets and MPTP-treated macaques), found that befiradol potently reduced Levodopa-induced dyskinesia at oral doses as low as 0.1 to 0.4 mg/kg.[14][15] In January 2018, the British charity Parkinson's UK announced that it had awarded Neurolixis a grant to advance development of befiradol up to clinical phase in Parkinson's disease patients.[16]

Clinical Ph2A Trial for dyskinesia in Parkinson's disease

In March 2019, Neurolixis announced that the US Food and Drug Administration (FDA) gave a positive response to Neurolixis' Investigational New Drug (IND) application for NLX-112 to be tested in a Phase 2 clinical study in Parkinson's disease patients with troublesome levodopa-induced dyskinesia.[17] On 22 November 2020, The Sunday Times reported that the two charities, Parkinson's UK and Michael J. Fox Foundation, were jointly investing $2 million to support a clinical trial on befiradol in Parkinson's disease patients with troublesome Levodopa-induced dyskinesia, a potentially "life changing" drug.[18] On 23 November 2020, Parkinson's UK and Michael J. Fox Foundation, confirmed their funding in an official announcement.[19] Neurolixis announced on 30 November 2021 the start of patient recruitment in the clinical trial. The trial is listed on the U.S. National Library of Medicine clinical trials register.[20] On 20 March 2023, a joint press release from Neurolixis, Parkinson's UK and Michael J. Fox Foundation announced that the clinical trial had met its primary endpoint of safety and tolerability, and also the secondary endpoint of efficacy in reducing Levodopa-induced dyskinesia in the patients.[21] Moreover, a later announcement (7 July 2023) disclosed that the clinical trial had also found that befiradol reduced parkinsonism symptoms (such as slowness of movement, tremor and rigidity), as well as Levodopa-induced dyskinesia, raising the prospect of developing a "dual-efficacy therapy" for Parkinson's disease.[22]

18F-Befiradol as an agonist PET radiotracer for brain imaging

As well as studies on befiradol for treatment of movement disorders, other researchers have investigated it as a novel radiotracer for brain imaging studies by positron emission tomography. Thus befiradol labeled with [18F] (also known as 18F-F13640) has been used to study the distribution of serotonin 5-HT1A receptors in rat, cat, macaque and human. Because befiradol is an agonist, it enables the detection of 5-HT1A receptors which are specifically in a functionally active state, whereas antagonist radiotracers label the total receptor population.[23][24]

See also

References

  1. ^ a b Newman-Tancredi A, Martel JC, Cosi C, Heusler P, Lestienne F, Varney MA, et al. (September 2017). "Distinctive in vitro signal transduction profile of NLX-112, a potent and efficacious serotonin 5-HT1A receptor agonist". The Journal of Pharmacy and Pharmacology. 69 (9): 1178–1190. doi:10.1111/jphp.12762. PMID 28612503. S2CID 13676820.
  2. ^ Lladó-Pelfort L, Assié MB, Newman-Tancredi A, Artigas F, Celada P (May 2012). "In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat". Psychopharmacology. 221 (2): 261–272. doi:10.1007/s00213-011-2569-9. PMID 22147258. S2CID 18779324.
  3. ^ Bardin L, Tarayre JP, Malfetes N, Koek W, Colpaert FC (April 2003). "Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain". Pharmacology. 67 (4): 182–194. doi:10.1159/000068404. PMID 12595749. S2CID 25882138.
  4. ^ Bruins Slot LA, Koek W, Tarayre JP, Colpaert FC (April 2003). "Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640". European Journal of Pharmacology. 466 (3): 271–279. doi:10.1016/S0014-2999(03)01566-8. PMID 12694810.
  5. ^ Bardin L, Assié MB, Pélissou M, Royer-Urios I, Newman-Tancredi A, Ribet JP, et al. (March 2005). "Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters". The Journal of Pharmacology and Experimental Therapeutics. 312 (3): 1034–1042. doi:10.1124/jpet.104.077669. PMID 15528450. S2CID 42446435.
  6. ^ Colpaert FC, Deseure K, Stinus L, Adriaensen H (February 2006). "High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning". The Journal of Pharmacology and Experimental Therapeutics. 316 (2): 892–899. doi:10.1124/jpet.105.095109. PMID 16254131. S2CID 8820667.
  7. ^ Deseure K, Bréand S, Colpaert FC (July 2007). "Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist". European Journal of Pharmacology. 568 (1–3): 134–141. doi:10.1016/j.ejphar.2007.04.022. PMID 17512927.
  8. ^ Bollinger S, Hübner H, Heinemann FW, Meyer K, Gmeiner P (October 2010). "Novel pyridylmethylamines as highly selective 5-HT(1A) superagonists". Journal of Medicinal Chemistry. 53 (19): 7167–7179. doi:10.1021/jm100835q. PMID 20860381.
  9. ^ Vacher B, Bonnaud B, Funes P, Jubault N, Koek W, Assié MB, et al. (May 1999). "Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors". Journal of Medicinal Chemistry. 42 (9): 1648–1660. CiteSeerX 10.1.1.325.8872. doi:10.1021/jm9806906. PMID 10229633.
  10. ^ "Neurolixis Announces In-Licensing of Two Clinical Compounds From Pierre Fabre Medicament" (PDF). Neurolixis, Inc. 23 September 2013.
  11. ^ "Parkinson's Disease Grants funded by the Michael J. Fox Foundation | Parkinson's Disease". The Michael J. Fox Foundation for Parkinson's Research | Parkinson's Disease. Retrieved 2017-06-23.
  12. ^ Iderberg H, McCreary AC, Varney MA, Kleven MS, Koek W, Bardin L, et al. (September 2015). "NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat". Experimental Neurology. 271: 335–350. doi:10.1016/j.expneurol.2015.05.021. PMID 26037043. S2CID 35525495.
  13. ^ McCreary AC, Varney MA, Newman-Tancredi A (June 2016). "The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements". Neuropharmacology. 105: 651–660. doi:10.1016/j.neuropharm.2016.01.013. PMID 26777281. S2CID 1979117.
  14. ^ Depoortere R, Johnston TH, Fox SH, Brotchie JM, Newman-Tancredi A (September 2020). "The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaques". Parkinsonism & Related Disorders. 78: 151–157. doi:10.1016/j.parkreldis.2020.08.009. PMID 32846366. S2CID 221343904.
  15. ^ Fisher R, Hikima A, Morris R, Jackson MJ, Rose S, Varney MA, et al. (May 2020). "The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and anti-parkinsonian-like effects in MPTP-treated marmosets". Neuropharmacology. 167: 107997. doi:10.1016/j.neuropharm.2020.107997. PMC 7103782. PMID 32057799.
  16. ^ "Investing in a new treatment for dyskinesia". Parkinson's UK. 24 January 2018.
  17. ^ "FDA Approves Neurolixis IND Application for a Clinical Trial with NLX-112 in Parkinson's Disease". Neurolixis, Inc. 12 March 2019 – via PRLog.
  18. ^ Gregory A (22 November 2020). "'Life-changing' drug to calm Parkinson's twitches set for human trials". Thetimes.co.uk.
  19. ^ "Global charities join forces to drive forward new drug for Parkinson's". The Michael J. Fox Foundation for Parkinson's Research (Press release) – via Cision US Inc.
  20. ^ Clinical trial number NCT05148884 for "Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia" at ClinicalTrials.gov
  21. ^ "Neurolixis Announces Positive Ph2A Proof-of-Concept on NLX-112 in Levodopa-Induced Dyskinesia in Parkinson's Disease". 20 March 2023 – via Newsmatics Inc.
  22. ^ Massey N (7 July 2023). "Researchers hopeful of treatment of Parkinson's by 2030 with 'dual efficacy' drug". The Independent. Retrieved 26 July 2023.
  23. ^ Colom M, Vidal B, Fieux S, Redoute J, Costes N, Lavenne F, et al. (2021). "[18F]F13640, a 5-HT1A Receptor Radiopharmaceutical Sensitive to Brain Serotonin Fluctuations". Frontiers in Neuroscience. 15: 622423. doi:10.3389/fnins.2021.622423. PMC 7982540. PMID 33762906.
  24. ^ Courault P, Lancelot S, Costes N, Colom M, Le Bars D, Redoute J, et al. (May 2023). "[18F]F13640: a selective agonist PET radiopharmaceutical for imaging functional 5-HT1A receptors in humans". European Journal of Nuclear Medicine and Molecular Imaging. 50 (6): 1651–1664. doi:10.1007/s00259-022-06103-1. PMC 10119077. PMID 36656363.

Read other articles:

Kepulauan Utara

Peta lokasi Kepulauan Utara Skotlandia. Kepulauan Utara (Inggris: Northern Islescode: en is deprecated ; Scots: Northren Islescode: sco is deprecated ; bahasa Gaelik Skotlandia: Na h-Eileanan a Tuath; bahasa Nordik Kuno: Norðreyjar) adalah serangkaian kepulauan di sebelah utara daratan Skotlandia. Iklim di kepulauan ini dingin dan sedang, dan dipengaruhi oleh laut di sekeliling. Terdapat dua kepulauan utama, yaitu Shetland dan Orkney. Orkney memiliki lanskap agrikultural yang subur, ...

 

 

Président de la Banque centrale européenne

Président de la Banque centrale européenne Titulaire actuelleChristine Lagardedepuis le 1er novembre 2019(4 ans, 5 mois et 2 jours) Création 1er juin 1998 Mandant Conseil européen Durée du mandat 8 ans, non renouvelable Premier titulaire Wim Duisenberg Rémunération Environ 400 000 euros annuel selon la Banque de France Site internet www.ecb.europa.eu modifier  Le président de la Banque centrale européenne, quelquefois appelé dans le langage courant «&...

 

 

العلاقات الجزائرية الدنماركية

العلاقات الجزائرية الدنماركية الجزائر الدنمارك   الجزائر   الدنمارك تعديل مصدري - تعديل   العلاقات الجزائرية الدنماركية هي العلاقات الثنائية التي تجمع بين الجزائر والدنمارك.[1][2][3][4][5] مقارنة بين البلدين هذه مقارنة عامة ومرجعية للدولتين: �...

Associazione Calcio Cuneo 1905 2012-2013

Voce principale: Associazione Calcio Cuneo 1905. Associazione Calcio Cuneo 1905Stagione 2012-2013Sport calcio Squadra Cuneo Allenatore Ezio Rossi All. in seconda Massimo Ferraris Presidente Marco Rosso Lega Pro Prima Divisione14º posto (retrocesso ai play-out) Coppa ItaliaPrimo turno Coppa Italia Lega ProPrimo turno Maggiori presenzeCampionato: Donida, Rossi (31)Totale: Donida (34) Miglior marcatoreCampionato: Cristini (7)Totale: Cristini (8) 2011-2012 2013-2014 Si invita a seguire il ...

 

 

Sony Ericsson W350i

Mobile phone model This article uses bare URLs, which are uninformative and vulnerable to link rot. Please consider converting them to full citations to ensure the article remains verifiable and maintains a consistent citation style. Several templates and tools are available to assist in formatting, such as reFill (documentation) and Citation bot (documentation). (August 2022) (Learn how and when to remove this template message) Sony Ericsson W350i, W350a, W350cManufacturerSony EricssonSeries...

 

 

Louis de La Vallée-Poussin

Bagian dari seri tentangBuddhisme SejarahPenyebaran Sejarah Garis waktu Sidang Buddhis Jalur Sutra Benua Asia Tenggara Asia Timur Asia Tengah Timur Tengah Dunia Barat Australia Oseania Amerika Eropa Afrika Populasi signifikan Tiongkok Thailand Jepang Myanmar Sri Lanka Vietnam Kamboja Korea Taiwan India Malaysia Laos Indonesia Amerika Serikat Singapura AliranTradisi Buddhisme prasektarian Aliran Buddhis awal Mahāsāṃghika Sthaviravāda Aliran arus utama Theravāda Mahāyāna Vajrayāna Kons...

Società Sportiva Calcio Giugliano 2000-2001

Voce principale: Associazione Sportiva Dilettantistica Giugliano 1928 Calcio. Società Sportiva Calcio GiuglianoStagione 2000-2001Sport calcio Squadra Giugliano Allenatore Ezio Castellucci poi Roberto Chiancone Presidente Giuseppe Loveri (amministratore unico) Serie C212º posto nel girone C. Maggiori presenzeCampionato: Balestrieri (32) Miglior marcatoreCampionato: Balestrieri (7) 1999-2000 2001-2002 Si invita a seguire il modello di voce Questa voce raccoglie le informazioni riguardan...

 

 

Piranha 3DD

2012 American 3D horror comedy film by John Gulager Piranha 3DDTheatrical release posterDirected byJohn GulagerWritten by Patrick Melton Marcus Dunstan Joel Soisson Based onCharactersby Peter GoldfingerJosh StolbergProduced by Mark Canton Marc Toberoff Joel Soisson Starring Danielle Panabaker Matt Bush David Koechner Chris Zylka Katrina Bowden Gary Busey Christopher Lloyd David Hasselhoff CinematographyAlexandre LehmannEdited by Devin C. Lussier Martin Bernfeld Kirk Morri Music byElia CmiralP...

 

 

Piatt Castles

Historic houses in Logan County, Ohio United States historic placeAbram S. Piatt House and Donn S. Piatt HouseU.S. National Register of Historic Places Mac-O-Chee and Mac-A-Cheek castlesInteractive map pinpointing the two housesLocation10051 Township Road 47 (Mac-A-Cheek); 2223 OH 287 (Mac-o-Chee), Monroe Township, Logan County, OhioCoordinates40°15′04″N 83°43′37″W / 40.251032°N 83.726808°W / 40.251032; -83.726808 (a)(Mac-A-Cheek), 40°15′30″N 8...

Raised beach

Emergent coastal landform Marine terrace redirects here. For the street in Fremantle, see Marine Terrace, Fremantle. Raised beach and marine terraces at Water Canyon beach A raised beach, now at 4 metres (13 ft) above high tide, formed King's Cave, Arran, below an earlier raised beach at around 30 metres (98 ft) height. A raised beach, coastal terrace,[1] or perched coastline is a relatively flat, horizontal or gently inclined surface of marine origin,[2] mostly an o...

 

 

Randecker Maar Research Station

Animal research station This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citations to reliable, independent, third-party sources. (December 2020) (Learn how and when to remove this message) The crater of the Randecker Maar volcano, cut open by erosion on its northern side. Through this gap in the Swabian Jura mountains, birds...

 

 

Les Paul

American guitarist, songwriter and inventor (1915–2009) This article is about the musician. For the guitar named after him, see Gibson Les Paul. Les PaulPaul c. January 1947Background informationBirth nameLester William PolsfussBorn(1915-06-09)June 9, 1915Waukesha, Wisconsin, U.S.DiedAugust 12, 2009(2009-08-12) (aged 94)White Plains, New York, U.S.GenresJazzcountrybluesrock and rollacoustic musicOccupation(s)MusiciansongwriterinventorluthierInstrument(s)VocalsguitarharmonicaYears...

Театр

У этого термина существуют и другие значения, см. Театр (значения). Театр  Медиафайлы на Викискладе Исполнительские искусства Акробатика Балет Цирк Клоунада Танец Гимнастика Иллюзионизм Мимы Музыка Опера Реслинг Театр кукол Ораторское искусство Стендап Театр Чревов�...

 

 

Sách cũ

Sách cũ đã qua sử dụng Chợ sách South Bank trước Nhà hát Phim Quốc gia, London, Anh, vào tháng 10 năm 2004 Hiệu sách ở Hay-on-Wye Sách đã qua sử dụng hoặc sách cũ là một cuốn sách đã được sở hữu trước đó bởi chủ sở hữu không phải là nhà xuất bản hoặc nhà bán lẻ, thường là của một cá nhân hoặc thư viện.[1] Sách đã qua sử dụng thường có sẵn trên thị trường khi chúng đư�...

 

 

30セント・メリー・アクス

30 St Mary Axe 概要用途 Office所在地 St. Mary Axe, City of London, United Kingdom座標 北緯51度30分52秒 西経00度04分49秒 / 北緯51.51444度 西経0.08028度 / 51.51444; -0.08028座標: 北緯51度30分52秒 西経00度04分49秒 / 北緯51.51444度 西経0.08028度 / 51.51444; -0.08028着工 2001完成 2003[1]開業 2004[2]高さ屋上 180メートル (591 ft)技術的詳細階数 40床面積 47,950平方�...

渡辺創

日本の政治家渡辺 創わたなべ そう 画像をアップロード生年月日 (1977-10-03) 1977年10月3日（47歳）出生地 日本 宮崎県宮崎市出身校 新潟大学法学部前職 毎日新聞記者所属政党 （民主党→）（民進党→）（旧立憲民主党→）立憲民主党公式サイト 宮崎県 立憲民主党県連代表 渡辺 創 衆議院議員選挙区 宮崎1区当選回数 1回在任期間 2021年11月2日[1] - 現職 宮崎県議会議�...

 

 

Klamath Air Force Station

Closed United States Air Force General Surveillance Radar station This article includes a list of general references, but it lacks sufficient corresponding inline citations. Please help to improve this article by introducing more precise citations. (December 2012) (Learn how and when to remove this message) Klamath Air Force Station Part of Air Defense Command (ADC)Klamath Air Force Station 1977Klamath AFSLocation of Klamath AFS, CaliforniaCoordinates41°33′33″N 124°05′10″W /...

 

 

Accordo Sykes-Picot

Questa voce o sezione sull'argomento trattati non cita le fonti necessarie o quelle presenti sono insufficienti. Puoi migliorare questa voce aggiungendo citazioni da fonti attendibili secondo le linee guida sull'uso delle fonti. Accordo sull'Asia MinoreMappa dell'accordo Sykes-Picot; allegato alla lettera di Paul Cambon a Sir Edward Grey, 9 maggio 1916.ContestoPrima guerra mondiale Firma16 maggio 1916 Parti Regno Unito di Gran Bretagna e Irlanda Repubblica francese Negoziatori Mark Syke...

John Singleton

American filmmaker (1968–2019) This article is about the American director. For other people named John Singleton, see John Singleton (disambiguation). John SingletonSingleton in 2000BornJohn Daniel Singleton(1968-01-06)January 6, 1968Los Angeles, California, U.S.DiedApril 28, 2019(2019-04-28) (aged 51)Los Angeles, California, U.S.Resting placeForest Lawn Memorial Park, Hollywood Hills, California, U.S.OccupationsDirectorscreenwriterproducerYears active1988–2019Spouse Akosua Bus...

 

 

Visual effects

Various processes by which imagery is created VFX redirects here. For the 1968 US Navy fighter program, see VFX (aircraft). This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: Visual effects – news · newspapers · books · scholar · JSTOR (February 2018) (Learn how and when to remove this message) Visual effects (...